ASCO 2020: Results of a study examining hospital readmission rates following treatment with CAR T axicabtagene ciloleucel for diffuse large b-cell lymphoma.
Home / Resource Library / Close Monitoring, Full-Time Caregiver Recommended for 30 Days After CAR-T Therapy